Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome
Diane M. Hargrove, Sudarkodi Alagarsamy, Glenn Croston, Régent Laporte, Steve Qi, Karthik Srinivasan, Javier Sueiras-Diaz, Kazimierz Wiśniewski, Jennifer Hartwig, Mark Lu, Alexander P. Posch, Halina Wiśniewska, Claudio D. Schteingart, Pierre Rivière, Violetta Dimitriadou
Topics & Concepts
PharmacokineticsPharmacologyIn vivoPotencyPharmacodynamicsShort bowel syndromeMedicineAgonistChemistryReceptorInternal medicineEndocrinologyIn vitroBiochemistryBiologyParenteral nutritionBiotechnologyClinical Nutrition and GastroenterologyGastroesophageal reflux and treatmentsDiabetes Treatment and Management